Primary care Osteoarthritis Screening Trial (POST): a cluster randomised trial of an electronic prompt for comorbidity screening in clinical osteoarthritis consultations in primary care

Conditions

Osteoarthritis Musculoskeletal Diseases Osteoarthritis

Elaine M. Hay, Krysia Dziedzic, Nadine E. Foster, George Peat, Daniëlle van der Windt et al. (25 authors)

Programme Grants for Applied Research2018-07-0121 citations

The effects of implementing a point-of-care electronic template to prompt routine anxiety and depression screening in patients consulting for osteoarthritis (the Primary Care Osteoarthritis Trial): A cluster randomised trial in primary care

Christian Mallen, Barbara I. Nicholl, Martyn Lewis, Bernadette Bartlam, Dan Green et al. (15 authors)

PLoS Medicine2017-04-1133 citations

10.1371/journal.pmed.1002273

Prognosis research ideally should measure time-varying predictors at their intended moment of use

Rebecca Whittle, Kara‐Louise Royle, Kelvin P. Jordan, Richard D Riley, Christian Mallen et al. (6 authors)

Diagnostic and Prognostic Research2017-01-2428 citations

10.1186/s41512-016-0006-6

Implementing the NICE osteoarthritis guidelines: a mixed methods study and cluster randomised trial of a model osteoarthritis consultation in primary care--the Management of OsteoArthritis In Consultations (MOSAICS) study protocol.

Dziedzic KS, Healey EL, Porcheret M, Ong BN, Main CJ, Jordan KP, Lewis M, Edwards JJ, Jinks C, Morden A, McHugh GA, Ryan S, Finney A, Jowett S, Oppong R, Afolabi E, Pushpa-Rajah A, Handy J, Clarkson K, Mason E, Whitehurst T, Hughes RW, Croft PR, Hay EM.

2014-08-2746 citations

10.1186/s13012-014-0095-y

Interventions

Generalised Anxiety Disorder-2 (GAD-2) 1. Eligible patients in the intervention arm consulting their GP for osteoarthritis or joint pain will be asked these 4 questions on depressive a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 45 years and over 2. Registered with the participating GP practices during the specified study period of that practice 3. Read-coded peripheral joint pain or OA consultation within the specified study period (termed the index consultation) 4. May be first, new episode, or ongoing consultation) 5. Provided full written informed consent to study participation and to further contact 6. Male & female

Exclusion criteria

Exclusion criteria: 1. Patients who are under active care for or who have a diagnosis of depression and/or an anxiety disorder in the past 12 months 2. Vulnerable patients, including any patients on the Quality and Outcomes Framework mental health register, or those who have a diagnosis of dementia or a terminal illness 3. Patients who reside in a nursing home 4. Red flag pathology 5. Recent trauma associated with significant injury 6. Acute, red, hot swollen joint 7. Inflammatory arthropathy, crystal disease, spondyloarthropathy and polymyalgia rheumatic

Design outcomes

Primary

Measure	Time frame
1. Self report measure of current pain intensity measured at baseline, 3 months, 6 months and 12 months	—

Secondary

Measure	Time frame
1. Anxiety (GAD-7 (5)) at baseline, 3 months, 6 months and 12 months 2. Body mass index (from self reported height and weight) at baseline, 3 months, 6 months and 12 months 3. Characteristic Pain Intensity and Disability Score at baseline, 3 months, 6 months and 12 months 4. Demographics (marital status and occupation/employment details) at baseline, 3 months, 6 months and 12 months 5. Depression (PHQ-8 (4)) at baseline, 3 months, 6 months and 12 months 6. Detailed questions about pain at baseline, 3 months, 6 months and 12 months 7. Medication and health care use at baseline, 3 months, 6 months and 12 months 8. Overall quality of life (EQ5D (2) and SF-36 (3)) at baseline, 3 months, 6 months and 12 months 9. Pain Catastrophising Scale (6) at baseline, 3 months, 6 months and 12 months 10. Pain interference with daily activities at baseline, 3 months, 6 months and 12 months 11. Social support (questions taken from previous postal surveys) at baseline, 3 months, 6 months and 12 months	—

Measure

Time frame

1. Anxiety (GAD-7 (5)) at baseline, 3 months, 6 months and 12 months 2. Body mass index (from self reported height and weight) at baseline, 3 months, 6 months and 12 months 3. Characteristic Pain Intensity and Disability Score at baseline, 3 months, 6 months and 12 months 4. Demographics (marital status and occupation/employment details) at baseline, 3 months, 6 months and 12 months 5. Depression (PHQ-8 (4)) at baseline, 3 months, 6 months and 12 months 6. Detailed questions about pain at baseline, 3 months, 6 months and 12 months 7. Medication and health care use at baseline, 3 months, 6 months and 12 months 8. Overall quality of life (EQ5D (2) and SF-36 (3)) at baseline, 3 months, 6 months and 12 months 9. Pain Catastrophising Scale (6) at baseline, 3 months, 6 months and 12 months 10. Pain interference with daily activities at baseline, 3 months, 6 months and 12 months 11. Social support (questions taken from previous postal surveys) at baseline, 3 months, 6 months and 12 months

—

Countries

United Kingdom

Outcome results

None listed